Patents Assigned to Protia, LLC
  • DEUTERIUM-ENRICHED ALFUZOSIN
    Publication number: 20090076043
    Abstract: The present application describes deuterium-enriched alfuzosin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W Czarnik
  • DEUTERIUM-ENRICHED DUTASTERIDE
    Publication number: 20090076057
    Abstract: The present application describes deuterium-enriched dutasteride, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 19, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED VORINOSTAT
    Publication number: 20090076154
    Abstract: The present application describes deuterium-enriched vorinostat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED FONDAPARINUX
    Publication number: 20090075910
    Abstract: The present application describes deuterium-enriched fondaparinux, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ENALAPRIL
    Publication number: 20090076126
    Abstract: The present application describes deuterium-enriched alendronate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RIVAROXABAN
    Publication number: 20090076264
    Abstract: The present application describes deuterium-enriched rivaroxaban, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: March 19, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED PACLITAXEL
    Publication number: 20090069410
    Abstract: The present application describes deuterium-enriched paclitaxel, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED PEMETREXED
    Publication number: 20090069349
    Abstract: The present application describes deuterium-enriched pemetrexed, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MILNACIPRAN
    Publication number: 20090069431
    Abstract: The present application describes deuterium-enriched milnacipran, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 3, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED AZTREONAM
    Publication number: 20090069286
    Abstract: The present application describes deuterium-enriched aztreonam, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 3, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MIGLUSTAT
    Publication number: 20090069375
    Abstract: The present application describes deuterium-enriched miglustat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SUGAMMADEX
    Publication number: 20090069412
    Abstract: The present application describes deuterium-enriched sugammadex, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ATRASENTAN
    Publication number: 20090069402
    Abstract: The present application describes deuterium-enriched atrasentan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TACROLIMUS
    Publication number: 20090069366
    Abstract: The present application describes deuterium-enriched tacrolimus, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 31, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED GEMCITABINE
    Publication number: 20090069354
    Abstract: The present application describes deuterium-enriched gemcitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 12, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED NEBIVOLOL
    Publication number: 20090069415
    Abstract: The present application describes deuterium-enriched nebivolol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 3, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED AMBRISENTAN
    Publication number: 20090069353
    Abstract: The present application describes deuterium-enriched ambrisentan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 12, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ATOMOXETINE
    Publication number: 20090069440
    Abstract: The present application describes deuterium-enriched atomoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED AROXIFENE
    Publication number: 20090069380
    Abstract: The present application describes deuterium-enriched arzoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TELAVANCIN
    Publication number: 20090069219
    Abstract: The present application describes deuterium-enriched telavancin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 31, 2008
    Publication date: March 12, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik